global schizophrenia drug market | PMI

News

Source: global schizophrenia drug market | PMI

The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of 2.7%. Primary factors driving the growth of the schizophrenia drug market is the rising population and increasing demands for the technological advancements. Factors such as the rising occurrence of schizophrenia, increasing personal healthcare expenditure, surging chronic ailments incidence, accelerating economic growth and unmet medical needs

---